pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Sep 3·1 min read
save

Health tech investors shift focus to larger funding rounds, Cityblock secures $116 million

Sep 3, 2026·read at Endpoints ↗DealPositive

Throughout the past year, investors in digital health have increasingly favored megafunding rounds rather than smaller seed or Series A deals.

In August, community-health startup Cityblock announced a $116 million Series round, illustrating the new scale of capital flowing into the sector.

The trend suggests that capital providers see greater upside in mature digital-health platforms, which could accelerate product development and market expansion for companies targeting integrated care solutions.

Analysts expect the shift toward larger rounds to continue as investors seek to back businesses with proven models and the potential for significant returns.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Health tech investors are looking at bigger bets”

read at Endpoints ↗
76 words · retrieved Sep 3
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 10h agoMerck reports mixed data for Lucentis competitor in diabetic macular edemaEndpoints
  • 11h agoAsahi Kasei lands approval for new HSV treatmentEndpoints
  • 13h agoMirum succeeds in rare liver disease trial; First Tracks delivers in celiacEndpoints
  • 13h agoBristol Myers reveals a pair of Phase 3 wins for fibrosis, RayzeBio drugsEndpoints
  • 13h agoBrent Saunders out as Bausch + Lomb CEO, an abrupt end to three-year runEndpoints